300313.SHE Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
- Market cap
- CNY 2.33B
- P/E
- -
- P/B
- 58.23x
- ROE
- 14.9%
- Dividend yield
- 0.19%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.
Is 300313.SHE undervalued?
Graham numberThe Graham number of Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd fundamental analysis
No fundamental analysis for Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd yet.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in the provision of cattle breeding products and services in China. The company offers frozen semen and embryos of self-produced breeding bulls, including breeds of Simmental, Brown, Holstein, Angus, Jersey, West Coast, and Charolais; Nine breeds of Limousin and Wagyu cattle; fattening cattle; and sheep frozen semen and embryo products. It is also involved in the young breeding of cows and pregnant cows; li…
Full company profileXinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd annual financial statements (CNY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 375M | 195M | 105M | 229M | 163M | 108M | 76.4M | 137M | 138M | 200M | 444M |
| Gross Profit | -68.0M | 76.3M | 25.1M | 16.1M | 26.4M | 2.92M | 9.29M | 15.4M | -18.1M | 14.8M | 38.3M |
| Operating Income | -192M | 11.2M | -1.84B | -92.3M | -7.97M | -28.1M | -28.2M | -18.7M | -61.3M | -5.19M | 12.3M |
| EBITDA | -137M | 54.6M | -1.90B | -20.0M | 33.3M | -82.1K | -3.09M | 4.71M | -43.3M | 809K | 18.1M |
| Net Income | -140M | 7.44M | -1.95B | -60.8M | 4.21M | -27.3M | -31.8M | -22.0M | -65.9M | -27.2M | 5.86M |
| EPS | -0.72 | 0.04 | -7.09 | -0.19 | 0.01 | -0.09 | -0.10 | -0.07 | -0.21 | -0.11 | 0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 855M | 691M | 1.40B | 1.14B | 907M | 843M | 332M | 315M | 248M | 280M | 306M |
| Total Liabilities | 454M | 328M | 1.20B | 997M | 758M | 728M | 238M | 243M | 243M | 235M | 251M |
| Shareholders' Equity | 368M | 364M | 209M | 149M | 155M | 104M | 84.3M | 62.2M | -3.78M | 31.6M | 39.4M |
| Cash & Short-term Investments | 162M | 28.5M | 242M | 22.1M | 16.3M | 109M | 47.3M | 16.7M | 24.5M | 39.4M | 17.0M |
| Total Debt | 314M | 214M | 362M | 204M | 222M | 221M | 182M | 177M | 83.1M | - | - |
| Cash Flow | |||||||||||
| Operating Cash Flow | 122M | 78.7M | -12.1M | -34.9M | 13.7M | -35.1M | -7.57M | -13.7M | 14.4M | 1.95M | - |
| Capital Expenditure | 76.5M | 18.4M | 13.9M | 13.4M | 13.6M | 2.09M | 1.65M | 1.65M | 2.68M | 6.18M | 7.54M |
| Free Cash Flow | 45.2M | 60.3M | -26.0M | -48.3M | 123K | -37.1M | -9.22M | -15.4M | 11.7M | -4.24M | -36.5M |
| Ratios | |||||||||||
| ROE | -38.0% | 2.0% | -930.9% | -40.7% | 2.7% | -26.2% | -37.8% | -35.4% | - | -85.9% | 14.9% |
| ROA | -16.3% | 1.1% | -138.7% | -5.3% | 0.5% | -3.2% | -9.6% | -7.0% | -26.6% | -9.7% | 1.9% |
| Net Profit Margin | -37.2% | 3.8% | -1,849.1% | -26.5% | 2.6% | -25.3% | -41.7% | -16.0% | -47.9% | -13.6% | 1.3% |
| Debt to Equity | 0.85x | 0.59x | 1.73x | 1.37x | 1.43x | 2.12x | 2.15x | 2.84x | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd dividends
- Dividend yield
- 0.19%
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- May 8, 2015
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | CNY 4.51M | 0.02 | - |
| 2024 | CNY 5.16M | 0.02 | - |
| 2023 | CNY 5.49M | 0.02 | - |
| 2022 | CNY 8.79M | 0.03 | - |
| 2021 | CNY 10.6M | 0.03 | - |
| 2020 | CNY 10.5M | 0.03 | 248.7% |
| 2019 | CNY 14.0M | 0.04 | - |
| 2018 | CNY 21.4M | 0.08 | - |
| 2017 | CNY 20.7M | 0.11 | 277.6% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 20:10 on May 8, 2015.
Who owns Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
- Insiders 64.22%
- Institutions 0.03%
- Public & others 35.74%
- Shares outstanding 240M
- Free float 76.3M
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd company profile
- Company name
- Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
- Ticker
- 300313.SHE
- ISIN
- CNE100001D62
- Exchange
- Shenzhen Stock Exchange
- Listed since
- Apr 25, 2012
- Sector
- Consumer Defensive
- Industry
- Biotechnology
- Employees
- 116
- Fiscal year end
- December
- Address
- No. 569, Beijing North Road, Changji, China, 831100
- Phone
- 86 99 4656 6618
- Website
- xjtssw.com
About Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd
Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. engages in the provision of cattle breeding products and services in China. The company offers frozen semen and embryos of self-produced breeding bulls, including breeds of Simmental, Brown, Holstein, Angus, Jersey, West Coast, and Charolais; Nine breeds of Limousin and Wagyu cattle; fattening cattle; and sheep frozen semen and embryo products. It is also involved in the young breeding of cows and pregnant cows; livestock technology information; technical services; live cattle and sheep; fresh meat products; ranch and agricultural land management and leasing services; and feed business. It serves live cattle circulation, slaughtering, and processing industry chains. Xinjiang Tianshan Animal Husbandry Bio-engineering Co., Ltd. was incorporated in 2003 and is headquartered in Changji, China.
Xinjiang Tianshan Animal Husbandry Bio-engineering Co Ltd management
4- Mr. Minghui HanCo-President, Secretary to the Board & Director · born 1987
- Mr. Qiang LiDeputy GM & Non-Independent Director · born 1972
- Mr. Jie ChenVP & Non-Independent Director · born 1987
- Mr. Jianjun GeVice President · born 1975